» Articles » PMID: 7054233

Fc and C3 Receptors Induced by Herpes Simplex Virus on Cultured Human Endothelial Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1982 Jan 1
PMID 7054233
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism by which immune complexes deposit in vascular tissue is uncertain. Several human viruses, including herpes simplex virus, have recently been demonstrated to replicate in human endothelial cells. Such viruses may injure vascular tissue and could play a role in the pathogenesis of immune complex deposition. Therefore, we studied the expression of receptors for immune complexes containing IgG and C3 on endothelial cells after infection with herpes simplex virus type I.Human umbilical vein endothelial cells were incubated with (51)Cr-labeled sheep erythrocytes sensitized with IgG, IgM, or IgM plus complement. Preferential binding of IgG or complement-coated erythrocytes to uninfected endothelial monolayers was not observed. In contrast, significant binding of erythrocytes coated with IgG or IgM plus complement was observed after viral infection. Phase-contrast and scanning electron microscopy demonstrated erythrocyte adherence around the infected endothelial cells in a rosette pattern. Binding of IgG-coated erythrocytes was fully inhibited by Fc (0.31 mg/ml) but not Fab' fragments of nonimmune IgG. Binding of complement-coated cells was unaffected by the presence of IgG (1 mg/ml). With purified individual components, binding of complement-coated erythrocytes depended on the presence and was proportional to the concentration of C3. Binding of IgG-or C3-coated cells was detected beginning 4 h after infection. These studies indicate that herpes simplex virus type I infection can induce IgG and C3 receptors on human endothelial cells. These receptors may promote the deposition of immune complexes in vascular tissue after certain viral infections.

Citing Articles

Virus-Encoded Complement Regulators: Current Status.

Sinha A, Singh A, Kadni T, Mullick J, Sahu A Viruses. 2021; 13(2).

PMID: 33573085 PMC: 7912105. DOI: 10.3390/v13020208.


Immunoglobulin g (IgG) expression in human umbilical cord endothelial cells.

Zhao Y, Liu Y, Chen Z, Korteweg C, Gu J J Histochem Cytochem. 2011; 59(5):474-88.

PMID: 21430258 PMC: 3201178. DOI: 10.1369/0022155411400871.


Isolation and function of a human endothelial cell C1q receptor.

Daha M, Dunn L, Berg R, Lange Y, Gerritsen A, Es L Mediators Inflamm. 1993; 2(6):447-52.

PMID: 18475561 PMC: 2365440. DOI: 10.1155/S096293519300064X.


Effect of antibody on the rickettsia-host cell interaction.

Feng H, Whitworth T, Popov V, Walker D Infect Immun. 2004; 72(6):3524-30.

PMID: 15155660 PMC: 415703. DOI: 10.1128/IAI.72.6.3524-3530.2004.


Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.

Langeggen H, Berge K, Johnson E, Hetland G Inflammation. 2002; 26(3):103-10.

PMID: 12083416 DOI: 10.1023/a:1015585530204.


References
1.
Ruddy S, Austen K . A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component. J Immunol. 1967; 99(6):1162-72. View

2.
Cooper N . Immune adherence by the fourth component of complement. Science. 1969; 165(3891):396-8. DOI: 10.1126/science.165.3891.396. View

3.
Lytle C . Host-cell reactivation in mammalian cells. I. Survival of ultra-violet-irradiated herpes virus in different cell-lines. Int J Radiat Biol Relat Stud Phys Chem Med. 1971; 19(4):329-37. DOI: 10.1080/09553007114550451. View

4.
Baringer J, Swoveland P . Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973; 288(13):648-50. DOI: 10.1056/NEJM197303292881303. View

5.
Jaffe E, Nachman R, Becker C, Minick C . Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973; 52(11):2745-56. PMC: 302542. DOI: 10.1172/JCI107470. View